Follow-on offering Announced
Perspective Therapeutics equity raising
US$175m raised
Announced 2 Feb 2026 · NYSE AMERICAN: CATX · US$3.79 cash per share
Advisers
Perspective Therapeutics
Issuer
- Financial adviser
- Jones
Lead managers
- Issuer
- Perspective Therapeutics
- Issuer based in
- United States
- Sector
- Radiopharmaceuticals
- Tags
- Radiopharmaceuticals, Oncology, Biotech
Similar deals
- Aktis Oncology IPO Jan 2026 · US$318m · Biotech
- Sensei Biotherapeutics placement Feb 2026 · US$200m · Biotech
- BlossomHill Therapeutics IPO Aug 2026 · US$150m · Biotech
- Avenzo Therapeutics placement Jun 2026 · US$215m · Biotech
- Pyxis Oncology equity raising Sep 2026 · US$110m · Biotech